These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17419693)

  • 61. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect.
    Huang XJ; Wang Y; Liu DH; Xu LP; Liu KY; Chen H; Chen YH; Han W; Shi HX
    Bone Marrow Transplant; 2009 Sep; 44(5):309-16. PubMed ID: 19234512
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel approaches in GVHD therapy.
    Svennilson J
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S65-7. PubMed ID: 15812534
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management.
    Chinnakotla S; Smith DM; Domiati-Saad R; Agura ED; Watkins DL; Netto G; Uemura T; Sanchez EQ; Levy MF; Klintmalm GB
    Liver Transpl; 2007 Jan; 13(1):157-61. PubMed ID: 17192857
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease.
    Leiter U; Kaskel P; Krähn G; Gottlöber P; Bunjes D; Peter RU; Kerscher M
    Photodermatol Photoimmunol Photomed; 2002 Aug; 18(4):183-90. PubMed ID: 12390673
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Pediatric Case of Sclerodermatous Graft-Versus-Host Disease Responsive to Ultraviolet A1 Phototherapy.
    Lazzeri L; Tripo L; Pescitelli L; Ricceri F; Prignano F
    Pediatr Dermatol; 2016; 33(2):e99-102. PubMed ID: 26871550
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography.
    Gottlöber P; Leiter U; Friedrich W; Bunjes D; Schulz A; Kerscher M; Peter RU
    J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):402-7. PubMed ID: 12834449
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of manual lymph drainage plus exercise on range of motion and flexibility in refractory chronic cutaneous graft-versus-host disease: A case report.
    Ozdemir K; Keser I; Yegin ZA; Kaynar LA
    Curr Res Transl Med; 2020 Jan; 68(1):1-4. PubMed ID: 31761680
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.
    Şanlı H; Akay BN; Soydan E; Koçyiğit P; Arat M; İlhan O
    Turk J Haematol; 2010 Jun; 27(2):91-8. PubMed ID: 27263450
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sclerodermatous chronic graft-versus-host disease presenting with dysphagia.
    Tamagawa R; Takenaka H; Katoh N; Shimazaki C; Bamba H; Kishimoto S
    Eur J Dermatol; 2006; 16(1):92-3. PubMed ID: 16436353
    [No Abstract]   [Full Text] [Related]  

  • 72. [Chronic sclerodermiform graft versus host disease (GvHD)].
    Müller-Serten B; Vakilzadeh F
    Hautarzt; 1994 Nov; 45(11):772-5. PubMed ID: 7822202
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.
    Eppinger T; Ehninger G; Steinert M; Niethammer D; Dopfer R
    Transplantation; 1990 Nov; 50(5):807-11. PubMed ID: 2238056
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dermatologic treatment of cutaneous graft versus host disease.
    Peñas PF; Fernández-Herrera J; García-Diez A
    Am J Clin Dermatol; 2004; 5(6):403-16. PubMed ID: 15663337
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sclerodermatous changes of chronic graft-versus-host-disease treated with puva.
    Woscoff A; Ruíz Lascano A; De Pablo AB; Robinson A
    Int J Dermatol; 1996 Sep; 35(9):656-8. PubMed ID: 8876297
    [No Abstract]   [Full Text] [Related]  

  • 76. Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients.
    Aubin F; Brion A; Deconinck E; Plouvier E; Hervé P; Humbert P; Cahn JY
    Transplantation; 1995 Jan; 59(1):151-5. PubMed ID: 7839420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sclerodermatous Graft-Versus-Host Disease: A Rare Sequela of Hematopoietic Stem Cell Transplantation.
    Jabin M; Batta S; Mian M; Parekh P
    Cureus; 2023 Oct; 15(10):e47963. PubMed ID: 38034201
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD.
    George L; George B; Gottlieb DJ; Hertzberg M; Fernandez-Peñas P
    Bone Marrow Transplant; 2012 May; 47(5):737-8. PubMed ID: 21785472
    [No Abstract]   [Full Text] [Related]  

  • 79. Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective.
    Molés-Poveda P; Montesinos P; Sanz-Caballer J; de Unamuno B; Piñana JL; Sahuquillo A; Botella-Estrada R
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):241-247. PubMed ID: 29254596
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Imatinib for sclerodermatous graft-versus-host disease in lung transplantation.
    Zhang J; Chen F; Ueki T; Date H
    Interact Cardiovasc Thorac Surg; 2015 Aug; 21(2):260-2. PubMed ID: 25972597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.